Journal of Hospice and Palliative Care

  • 제16권4호
  • /
  • Pages.205-215
  • /
  • 2013
  • /
  • 2765-3072(pISSN)
  • /
  • 2765-3080(eISSN)
한국호스피스완화의료학회 (Korean Society for Hospice and Palliative Care)
권호 표지
DOI QR코드

DOI QR Code

말기암환자에서 통증 외 증상의 관리: 최신 NCCN(National Comprehensive Cancer Netweork) 권고안을 중심으로

Management of Non-pain Symptoms in Terminally Ill Cancer Patients: Based on National Comprehensive Cancer Network Guidelines

  • 이혜란 (인제대학교 일산백병원 혈액종양내과)
  • Lee, Hye Ran (Division of Hemato/Oncology, Department of Internal Medicine, Inje University Ilsan Paik Hospital)
  • 투고 : 2013.11.02
  • 심사 : 2013.11.21
  • 발행 : 2013.12.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

말기암환자들은 암의 진행으로 인한 여러 가지 육체적, 정신적 증상들로 고통 받고 있으며, 통증뿐만 아니라 피로감, 쇠약감, 식욕부진, 오심 구토, 호흡곤란 등은 말기암환자의 삶의 질 감소에 큰 영향을 미친다. 피로감은 여러 기전 및 원인에 의하여 발생하는데, 치료 가능한 원인으로는 약물부작용, 빈혈, 심한 통증, 수면장애, 우울증 또는 불안감, 영양부족, 내과적 동반질환 등이다. 피로감의 주 기전으로는 사이토카인의 조절이상 및 시상하부-뇌하수체-부신축의 기능부전, serotonin의 조절이상 생체리듬의 파괴, ATP에서의 변화 등이다. 치료는 치료 가능한 원인을 제거하고 환자의 에너지를 보존할 수 있게 하는 방향으로 활동을 계획하고, 교육해야 하며, 약물 치료로는 corticosteroid와 psychostimulants를 사용할 수 있다. 식욕부진과 악액질도 여러 가지 치료 가능한 원인이 있을 수 있는데, 구내염, 구강 캔디다증, 구강 herpes, 구강건조, 변비, 통증과 호흡곤란같이 조절이 안 되는 증상, 섬망, 오심 구토, 우울증, 위장관 운동기능 장애, 역류성 식도염, 내분비 장애가 포함 된다. 식욕부전의 기전은 음식섭취를 조절하는 뇌의 생리적 기전의 이상과 관련, serotonin 분비 증가, IL-$1{\alpha}$, IL-1, IL-6, IL-8 TNF-${\alpha}$와 관련이 있다. 악액질의 기전은 에너지와 기질(substrate metabolism)에서의 변화, 종양에서 생산된 지질분해요소와 단백질 분해요소, 호르몬 이상, 암세포로부터 세포성장에 필요한 영양분을 빼앗기는 것, 에너지 섭취의 감소 등이다. 치료는 정신과 상담 및 환자와 가족의 교육인데, 교육할 때는 환자와 그 가족에게 식욕부진과 악액질이 암으로 인한 임종과정 중 일어나는 자연적인 현상이라는 것을 알리며, 다른 행동으로 환자를 돌보는 방법 등을 교육한다. 약물치료로는 megestrol acetate와 dronabinol, steroid를 사용할 수 있다. 오심 구토의 원인 중 치료가 가능할 수도 있는 것으로는 약물, 요독증, 감염, 불안증, 변비, 상부위장관 폐쇄, 고칼슘혈증, 저나트륨증이 있고, 치료는 metoclopramide, haloperidol, olanzapine 또는 ondansetron 등을 사용해 볼 수 있다. 말기 암에서 호흡곤란의 증상은 폐의 특별한 병변이 없이도 환자가 호소할 수 있는데, 이 경우 opioids가 효과적이다. 말기 암환자에서 환자의 증상을 경감시켜주기 위한 완화치료는 매우 중요하며, 환자의 증상을 잘 평가하고 적절한 치료 및 관리를 해 줌으로써 환자의 삶의 질을 향상시킬 수 있다. 따라서 이들 환자의 증상 호소에 더욱 관심을 갖고 적극적으로 치료하고 관리하여야 할 것이다.

Most terminally ill cancer patients experience various physical and psychological symptoms during their illness. In addition to pain, they commonly suffer from fatigue, anorexia-cachexia syndrome, nausea, vomiting and dyspnea. In this paper, I reviewed some of the common non-pain symptoms in terminally ill cancer patients, based on the National Comprehensive Cancer Network (NCCN) guidelines to better understand and treat cancer patients. Cancer-related fatigue (CRF) is a common symptom in terminally ill cancer patients. There are reversible causes of fatigue, which include anemia, sleep disturbance, malnutrition, pain, depression and anxiety, medical comorbidities, hyperthyroidism and hypogonadism. Energy conservation and education are recommended as central management for CRF. Corticosteroid and psychostimulants can be used as well. The anorexia and cachexia syndrome has reversible causes and should be managed. It includes stomatitis, constipation and uncontrolled severe symptoms such as pain or dyspnea, delirium, nausea/vomiting, depression and gastroparesis. To manage the syndrome, it is important to provide emotional support and inform the patient and family of the natural history of the disease. Megesteol acetate, dronabinol and corticosteroid can be helpful. Nausea and vomiting will occur by potentially reversible causes including drug consumption, uremia, infection, anxiety, constipation, gastric irritation and proximal gastrointestinal obstruction. Metoclopramide, haloperidol, olanzapine and ondansetron can be used to manage nausea and vomiting. Dyspnea is common even in terminally ill cancer patients without lung disease. Opioids are effective for symptomatic management of dyspnea. To improve the quality of life for terminally ill cancer patients, we should try to ameliorate these symptoms by paying more attention to patients and understanding of management principles.

키워드

참고문헌

  1. Ross DD, Alexander CS. Management of common symptoms in terminally ill patients: Part I. Fatigue, anorexia, cachexia, nausea and vomiting. Am Fam Physician 2001;64:807-14.
  2. Tsai JS, Wu CH, Chiu TY, Hu WY, Chen CY. Symptom patterns of advanced cancer patients in a palliative care unit. Palliat Med 2006;20:617-22. https://doi.org/10.1177/0269216306071065
  3. Von Roenn JH, Paice JA. Control of common, non-pain cancer symptoms. Semin Oncol 2005;32:200-10. https://doi.org/10.1053/j.seminoncol.2004.11.019
  4. Shoemaker LK, Eastfan B, Induru R, Walsh TD. Symptom management: an important part of cancer care. Cleve Clin J Med 2011;78:25-34. https://doi.org/10.3949/ccjm.78a.10053
  5. Kim Y. Symptom management for cancer patients. Korean J Hosp Palliat Care 2012;15:61-7.
  6. Hwang SW. Symptom clusters in advanced cancer patients. Korean J Hosp Palliat Care 2013;16:139-44. https://doi.org/10.14475/kjhpc.2013.16.3.139
  7. Hwang SS, Chang VT, Cogswell J, Kasimis BS. Clinical relevance of fatigue levels in cancer patients at a Veterans Administration Medical Center. Cancer 2002;94:2481-9. https://doi.org/10.1002/cncr.10507
  8. Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanism of cancer-related fatigue. Oncologist 2007;12 Suppl 1:22-34. https://doi.org/10.1634/theoncologist.12-S1-22
  9. Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M; GENEQOL Consortium. I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res 2010;19:1419-27. https://doi.org/10.1007/s11136-010-9757-7
  10. National Comprehensive Cancer Network. NCCN practice guidelines [Internet]. Version 1. Fort Washington, PA: National Comprehensive Cancer Network; c2013. 2013 for Cancer-related fatigue [cited 2013 Oct 19]. Available from: http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf.
  11. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999;85:1186-96. https://doi.org/10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N
  12. Yun YH, Wang XS, Lee JS, Roh JW, Lee CG, Lee WS, et al. Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage 2005;29:165-72. https://doi.org/10.1016/j.jpainsymman.2004.04.013
  13. Kwak SM, Choi YS, Yoon HM, Kim DG, Song SH, Lee YJ, et al. The relationship between interleukin-6, tumor necrosis factor-${\alpha}$, and fatigue in terminally ill cancer patients. Palliat Med 2012;26:275-82. https://doi.org/10.1177/0269216311406991
  14. Crews DJ, Landers DM. A meta-analytic review of aerobic fitness and reactivity to psychosocial stressors. Med Sci Sports Exerc 1987;19(5 Suppl):S114-20.
  15. Sarhill N, Walsh D, Nelson KA, Homsi J, LeGrand S, Davis MP. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care 2001;18:187-92. https://doi.org/10.1177/104990910101800310
  16. DeWys WD. Weight loss and nutritional abnormalities in cancer patients: incidence, severity and significance. Clin Oncol 1986;5:251-61.
  17. Tisdale MJ. Cancer anorexia and cachexia. Nutrition 2001;17:438-42. https://doi.org/10.1016/S0899-9007(01)00506-8
  18. Nicolini A, Ferrari P, Masoni MC, Fini M, Pagani S, Giampietro O, et al. Malnutrition, anorexia and cachexia in cancer patients: A mini-review on pathogenesis and treatment. Biomed Pharmarcother 2013;67:807-17. https://doi.org/10.1016/j.biopha.2013.08.005
  19. National Comprehensive Cancer Network. NCCN practice guidelines [Internet]. Version 2. Fort Washington, PA: National Comprehensive Cancer Network; c2013. 2013 for Palliative care: anorexia/cachexia [cited 2013 Oct 19]. Available from: http://www.nccn.org/professionals/physician_gls/PDF/palliativecare.pdf.
  20. Loprinzi CL, Michalak JC, Schaid DJ, Mailliard JA, Athmann LM, Goldberg RM, et al. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 1993;11:762-7. https://doi.org/10.1200/JCO.1993.11.4.762
  21. Nelson K, Walsh D, Deeter P, Sheehan F. A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancerassociated anorexia. J Palliat Care 1994;10:14-8.
  22. Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR Milliard JA, et al. Dronabinol versus megestro acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol 2002;20:567-73. https://doi.org/10.1200/JCO.20.2.567
  23. Mercadante S, Fulfaro F, Casuccio A. The use of corticosteroids in home palliative care. Support Care Cancer 2001;9:386-9. https://doi.org/10.1007/s005200000218
  24. Chlebowski RT, Herrold J, Ali I, Oktay E, Chlebowski JS, Ponse AT, et al. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer. Cancer 1986;58:183-6. https://doi.org/10.1002/1097-0142(19860701)58:1<183::AID-CNCR2820580131>3.0.CO;2-3
  25. Tchekmedyian S, Thropay J, von Roenn J, Ottery F. Patients with aerodigestive tract cancer and pre-existing weight loss: performance status, quality of life, and laboratory parameters with oxandrolone use. IJROBP 2002;54(2 Suppl):311-2.
  26. Bruera E, Strasser F, Palmer JL, Willey J, Calder K, Amyotte G, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol 2003;21:129-34. https://doi.org/10.1200/JCO.2003.01.101
  27. Stephenson J, Davies A. An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer 2006;14:348-53. https://doi.org/10.1007/s00520-005-0897-1
  28. National Comprehensive Cancer Network. NCCN practice guidelines [Internet]. Version 2. Fort Washington, PA: National Comprehensive Cancer Network; c2013. 2013 for Palliative care: nausea/vomiting [cited 2013 Oct 19]. Available from: http://www.nccn.org/professionals/physician_gls/PDF/palliativecare.pdf.
  29. Escalante CP, Martin CG, Elting LS, Cantor SB, Harle TS, Price KJ, et al. Dyspnea in cancer patients. Etiology, resource utilization, and survival-implications in a managed care world. Cancer 1996;78:1314-9. https://doi.org/10.1002/(SICI)1097-0142(19960915)78:6<1314::AID-CNCR21>3.0.CO;2-2
  30. Escalante CP, Martin CG, Elting LS, Price KJ, Manzullo EF, Weiser MA, et al. Identifying risk factors for imminent death in cancer patients with acute dyspnea. J Pain Symptom Manage 2000;20:318-25. https://doi.org/10.1016/S0885-3924(00)00193-7
  31. National Comprehensive Cancer Network. NCCN practice guidelines [Internet]. Version 2. Fort Washington, PA: National Comprehensive Cancer Network; c2013. 2013 for Palliative care: dyspnea [cited 2013 Oct 19]. Available from: http://www.nccn.org/professionals/physician_gls/PDF/palliativecare.pdf.
  32. Thomas JR, von Gunten CF. Clinical management of dyspnea. Lancet Oncol 2002;3:223-8. https://doi.org/10.1016/S1470-2045(02)00713-1
  33. Thomas JR, von Gunten CF. Management of dyspnea. J Support Oncol 2003;1:23-32.
  34. Bruera E, MacEachern T, Ripamonti C, Hanson J. Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med 1993;119:906-7. https://doi.org/10.7326/0003-4819-119-9-199311010-00007
  35. Clemens KE, Quednau I, Klaschik E. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study. Support Care Cancer 2009;17:367-77. https://doi.org/10.1007/s00520-008-0479-0

피인용 문헌

  1. Development of e-learning Education Programs for Social Workers in Hospice and Palliative Care vol.18, pp.1, 2015, https://doi.org/10.14475/kjhpc.2015.18.1.9
  2. The Relationship between Opioids Use, Cortisol and DHEAS vol.18, pp.2, 2015, https://doi.org/10.14475/kjhpc.2015.18.2.105
  3. Family Caregivers' Quality of Life, Depression and Anxiety according to Symptom Control in Hospice Patients vol.18, pp.4, 2015, https://doi.org/10.14475/kjhpc.2015.18.4.314
  4. Study of comprehensive and integrative treatment using acupuncture for cancer pain through publication review vol.26, pp.6, 2015, https://doi.org/10.7465/jkdi.2015.26.6.1327
  5. Retrospective Cohort Study on the Administration of Sedative for Delirium in Terminally Ill Cancer Patients and Survival Time vol.19, pp.2, 2016, https://doi.org/10.14475/kjhpc.2016.19.2.119
  6. 암환자를 위한 통합적 완화 돌봄 측정도구 개발 및 평가 vol.23, pp.2, 2013, https://doi.org/10.5977/jkasne.2017.23.2.165
  7. 악액질(cachexia) 환자에게 적용한 운동치료가 피로와 불안에 미치는 영향(단일사례 보고) vol.6, pp.4, 2013, https://doi.org/10.15268/ksim.2018.6.4.111
  8. 웃음요법이 호스피스 입원환자의 기분상태, 통증 및 스트레스에 미치는 효과 vol.10, pp.11, 2019, https://doi.org/10.15207/jkcs.2019.10.11.481